发明名称 ERGOLINE 1 DERIVATIVES
摘要 The present invention provides compounds of formula I, <IMAGE> I wherein X is hydrogen, chlorine or bromine, R1 is methyl or ethyl, R2 is alkyl of 1 to 4 carbon atoms or allyl, R3 is CH2CN or a group -NR4R5, wherein R4 is hydrogen or alkyl of 1 to 4 carbon atoms, and R5 is alkanoyl of 1 to 5 carbon atoms, alkoxycarbonyl of 2 to 5 carbon atoms in the aggregate thereof, or mono-, di- or tri-haloalkoxycarbonyl of 3 to 5 carbon atoms, wherein the alkoxy group is substituted by halogen other than in the alpha position to the oxygen atom, or R5 is SO2R6, wherein R6 is alkyl of 1 to 4 carbon atoms, mono-, di- or tri-haloalkyl of 1 to 4 carbon atoms, phenyl, phenyl mono-substituted by halogen or alkoxy of 1 to 4 carbon atoms, or pyridyl, or R6 is a group NR7R8, wherein R7 and R8 are, independently, hydrogen or alkyl of 1 to 4 carbon atoms, or R7 and R8 together form -[CH2]n- or -[CH2]2-A-[CH2]2-, wherein n is a whole number from 3 to 7, and A is oxygen, sulphur, or nitrogen substituted by alkyl of 1 to 4 carbon atoms or phenyl which are useful as prolactin inhibitors, anti-parkinson agents, and anti-depressants.
申请公布号 HK3483(A) 申请公布日期 1983.01.20
申请号 HK19830000034 申请日期 1983.01.20
申请人 SANDOZ LTD 发明人 STUETZ PETER;FEHR THEODOR;STADLER PAUL
分类号 C07D457/02;A61K31/48;A61K31/535;A61P25/00;A61P25/24;A61P25/26;C07D457/04;C07D457/06;C07D457/12;(IPC1-7):C07D457/12 主分类号 C07D457/02
代理机构 代理人
主权项
地址